화이자와 BioNTech 코로나19 백신, 긍정적 결과 보여줘
- 두 회사가 개발 중인 코로나19 백신의 임상, 건강한 환자에 면역 반응 보여
- 그러나 특히 더 높은 양 투여에서 열과 다른 부작용을 초래해
- 첫 임상 데이터, 수요일 MedRXiv에 실렸지만 아직 피어리뷰는 거치지 않아 https://t.co/lHPlWSUUhs

— Wan Ki Choi (@wkchoi) July 1, 2020

BREAKING: Coronavirus vaccine from Pfizer and BioNTech shows positive results https://t.co/kbrTQuoJd7

— CNBC Now (@CNBCnow) July 1, 2020

BREAKING: Coronavirus vaccine from Pfizer and BioNTech shows positive resultshttps://t.co/0lkEJwwx2f

— The Stock Sniper (@Ultra_Calls) July 1, 2020

Good news ??https://t.co/0DaBB560Uy

— Rajasekar (@sekartweets) July 1, 2020

BREAKING: #Coronavirus vaccine from #Pfizer and #BioNTech shows positive results - CNBC https://t.co/m3xEhPSo6r

— حسن سجواني ?? Hassan Sajwani (@HSajwanization) July 1, 2020

Pfizer, Biontech shares surge in pre-market trading after vaccine from the companies shows positive results https://t.co/Uyu94zmCFS pic.twitter.com/M2zUljRRGZ

— CNBC Now (@CNBCnow) July 1, 2020

Holy cow!!! You have all been waiting to hear. Me too!!!!!! https://t.co/UXsV56ytlC

— Andrew Rubin (@RubinHealth) July 1, 2020

BioNTech and Pfizer’s Covid-19 vaccine trial yields positive results https://t.co/rdtySNR2oU

— FT Health (@fthealth) July 1, 2020

BioNTech & Pfizer's Covid trial: 24 people between 18-55 who received 2 doses of vaccine had “significantly elevated” antibodies within 4 weeks of 1st injection. Using messenger RNA (mRNA) technology which is faster than traditional vaccine development. https://t.co/dmPuVO9XO1

— Linda Yueh (@lindayueh) July 1, 2020

BioNTech and Pfizer’s Covid-19 vaccine trial yields positive results

https://t.co/BEKBVfU9SV

— Ajay Bagga (@Ajay_Bagga) July 1, 2020

BioNTech and Pfizer’s Covid-19 vaccine trial yields positive results https://t.co/ZGfRRZYppQ

— tyro (@DoubleEph) July 1, 2020

BioNTech and Pfizer’s Covid-19 vaccine trial yields positive results https://t.co/3it5vdVojO

— Financial Times (@FT) July 1, 2020

GOOD-F*CKIN NEWS!
*considering the circumstances*

BioNTech and Pfizer’s Covid-19 vaccine trial yields positive results https://t.co/sFX440bVUZ via @financialtimes

— Defeat Corona (@NoSylviaPlath) July 1, 2020

? SCOOP: BioNTech becomes the first ?? group to publish preliminary results of Covid-19 vaccine trial.

Participants in US study, with Pfizer, developed antibodies stronger than those of the average recovered Covid-19 patient.https://t.co/lZqRUYNHRR

— Joe Miller (@JoeMillerJr) July 1, 2020